U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Acute lymphoid leukemia(ALL)

MedGen UID:
7317
Concept ID:
C0023449
Neoplastic Process
Synonyms: Acute lymphoblastic leukemia; Acute lymphocytic leukemia; ALL; Familial Acute Lymphocytic Leukemia; Leukemia, acute lymphoblastic, somatic; Lymphoblastic leukemia
SNOMED CT: ALL - Acute lymphoblastic leukemia (91857003); Acute lymphoid leukemia (91857003); Lymphoblastic leukemia (128822004); Acute lymphocytic leukemia (128822004); Acute lymphoblastic leukemia-lymphoma (128822004); Acute lymphoblastic leukemia (128822004); Acute lymphatic leukemia (128822004); Acute lymphoid leukemia, disease (91857003)
 
Genes (locations): BAX (19q13.33); BCR (22q11.23); FLT3 (13q12.2); GNB1 (1p36.33); NBN (8q21.3); NUP214 (9q34.13); TAL1 (1p33); TAL2 (9q31.2)
 
HPO: HP:0006721
Monarch Initiative: MONDO:0004967
OMIM®: 613065
Orphanet: ORPHA513

Definition

Acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia, is a subtype of acute leukemia, a cancer of the white blood cells. Somatically acquired mutations in several genes have been identified in ALL lymphoblasts, cells in the early stages of differentiation. Germline variation in certain genes may also predispose to susceptibility to ALL (Trevino et al., 2009). Genetic Heterogeneity of Acute Lymphoblastic Leukemia A susceptibility locus for acute lymphoblastic leukemia (ALL1) has been mapped to chromosome 10q21. See also ALL2 (613067), which has been mapped to chromosome 7p12.2; and ALL3 (615545), which is caused by mutation in the PAX5 gene (167414) on chromosome 9p. [from OMIM]

Clinical features

From HPO
Acute lymphoid leukemia
MedGen UID:
7317
Concept ID:
C0023449
Neoplastic Process
Acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia, is a subtype of acute leukemia, a cancer of the white blood cells. Somatically acquired mutations in several genes have been identified in ALL lymphoblasts, cells in the early stages of differentiation. Germline variation in certain genes may also predispose to susceptibility to ALL (Trevino et al., 2009). Genetic Heterogeneity of Acute Lymphoblastic Leukemia A susceptibility locus for acute lymphoblastic leukemia (ALL1) has been mapped to chromosome 10q21. See also ALL2 (613067), which has been mapped to chromosome 7p12.2; and ALL3 (615545), which is caused by mutation in the PAX5 gene (167414) on chromosome 9p.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  

Conditions with this feature

Ataxia-telangiectasia syndrome
MedGen UID:
439
Concept ID:
C0004135
Disease or Syndrome
Classic ataxia-telangiectasia (A-T) is characterized by progressive cerebellar ataxia beginning between ages one and four years, oculomotor apraxia, choreoathetosis, telangiectasias of the conjunctivae, immunodeficiency, frequent infections, and an increased risk for malignancy, particularly leukemia and lymphoma. Individuals with A-T are unusually sensitive to ionizing radiation. Non-classic forms of A-T have included adult-onset A-T and A-T with early-onset dystonia.
Acute lymphoid leukemia
MedGen UID:
7317
Concept ID:
C0023449
Neoplastic Process
Acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia, is a subtype of acute leukemia, a cancer of the white blood cells. Somatically acquired mutations in several genes have been identified in ALL lymphoblasts, cells in the early stages of differentiation. Germline variation in certain genes may also predispose to susceptibility to ALL (Trevino et al., 2009). Genetic Heterogeneity of Acute Lymphoblastic Leukemia A susceptibility locus for acute lymphoblastic leukemia (ALL1) has been mapped to chromosome 10q21. See also ALL2 (613067), which has been mapped to chromosome 7p12.2; and ALL3 (615545), which is caused by mutation in the PAX5 gene (167414) on chromosome 9p.
Dubowitz syndrome
MedGen UID:
59797
Concept ID:
C0175691
Disease or Syndrome
Dubowitz syndrome (DS) is a rare multiple congenital syndrome characterized primarly by growth retardation, microcephaly, distinctive facial dysmorphism, cutaneous eczema, a mild to severe intellectual deficit and genital abnormalities.
DNA ligase IV deficiency
MedGen UID:
339855
Concept ID:
C1847827
Disease or Syndrome
LIG4 syndrome is an autosomal recessive severe combined immunodeficiency with features of radiosensitivity, chromosomal instability, pancytopenia, and developmental and growth delay. Leukemia and dysmorphic facial features have been reported in some patients (summary by van der Burg et al., 2006).
CHIME syndrome
MedGen UID:
341214
Concept ID:
C1848392
Disease or Syndrome
CHIME syndrome, also known as Zunich neuroectodermal syndrome, is an extremely rare autosomal recessive multisystem disorder clinically characterized by colobomas, congenital heart defects, migratory ichthyosiform dermatosis, mental retardation, and ear anomalies (CHIME). Other clinical features include distinctive facial features, abnormal growth, genitourinary abnormalities, seizures, and feeding difficulties (summary by Ng et al., 2012). The disorder is caused by a defect in glycosylphosphatidylinositol (GPI) biosynthesis. For a discussion of genetic heterogeneity of GPI biosynthesis defects, see GPIBD1 (610293).
Noonan syndrome 2
MedGen UID:
344290
Concept ID:
C1854469
Disease or Syndrome
Noonan syndrome (NS) is characterized by characteristic facies, short stature, congenital heart defect, and developmental delay of variable degree. Other findings can include broad or webbed neck, unusual chest shape with superior pectus carinatum and inferior pectus excavatum, cryptorchidism, varied coagulation defects, lymphatic dysplasias, and ocular abnormalities. Although birth length is usually normal, final adult height approaches the lower limit of normal. Congenital heart disease occurs in 50%-80% of individuals. Pulmonary valve stenosis, often with dysplasia, is the most common heart defect and is found in 20%-50% of individuals. Hypertrophic cardiomyopathy, found in 20%-30% of individuals, may be present at birth or develop in infancy or childhood. Other structural defects include atrial and ventricular septal defects, branch pulmonary artery stenosis, and tetralogy of Fallot. Up to one fourth of affected individuals have mild intellectual disability, and language impairments in general are more common in NS than in the general population.
Lymphoblastic leukemia, acute, with lymphomatous features
MedGen UID:
340879
Concept ID:
C1855472
Neoplastic Process
Pancytopenia due to IKZF1 mutations
MedGen UID:
905078
Concept ID:
C4225173
Disease or Syndrome
Common variable immunodeficiency-13 (CVID13) is an autosomal dominant primary immunodeficiency disorder characterized by recurrent bacterial infections, mainly affecting the respiratory tract, and associated with hypogammaglobulinemia and decreased numbers of B cells. The age at onset of clinical features can range from infancy to adulthood, and some patients may have a mild disorder or even remain clinically asymptomatic (summary by Kuehn et al., 2016). For a general description and a discussion of genetic heterogeneity of common variable immunodeficiency, see CVID1 (607594).
Kostmann syndrome
MedGen UID:
1713491
Concept ID:
C5235141
Disease or Syndrome
Severe congenital neutropenia-3 is an autosomal recessive bone marrow failure disorder characterized by low numbers of neutrophils, increased susceptibility to bacterial and fungal infections, and increased risk of developing myelodysplastic syndrome or acute myeloid leukemia. In addition, patients with HAX1 mutations affecting both isoform A and B of the gene develop neurologic abnormalities (summary by Boztug et al., 2010). The Swedish physician Rolf Kostmann (1956) described an autosomal recessive hematologic disorder, termed infantile agranulocytosis, with severe neutropenia with an absolute neutrophil count below 0.5 x 10(9)/l and early onset of severe bacterial infections. The disorder was later termed Kostmann syndrome (Skokowa et al., 2007). Lekstrom-Himes and Gallin (2000) discussed severe congenital neutropenia in a review of immunodeficiencies caused by defects in phagocytes. In addition to Kostmann agranulocytosis, recessively inherited neutropenic syndromes include congenital neutropenia with eosinophilia (257100), Chediak-Higashi syndrome (214500), and Fanconi pancytopenic syndrome (see 227650). For a phenotypic description and a discussion of genetic heterogeneity of severe congenital neutropenia, see SCN1 (202700).

Professional guidelines

PubMed

Girard S, Fenneteau O, Mestrallet F, Troussard X, Lesesve JF
Ann Biol Clin (Paris) 2017 Oct 1;75(5):503-512. doi: 10.1684/abc.2017.1250. PMID: 28853417
Bodet-Milin C, Kraeber-Bodéré F, Eugène T, Guérard F, Gaschet J, Bailly C, Mougin M, Bourgeois M, Faivre-Chauvet A, Chérel M, Chevallier P
Semin Nucl Med 2016 Mar;46(2):135-46. doi: 10.1053/j.semnuclmed.2015.10.007. PMID: 26897718
Relling MV, Ramsey LB
Hematology Am Soc Hematol Educ Program 2013;2013:126-30. doi: 10.1182/asheducation-2013.1.126. PMID: 24319173

Curated

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Lymphoblastic Leukemia, 2024

Recent clinical studies

Etiology

Wadai GMA
Arch Razi Inst 2022 Oct;77(5):1895-1899. Epub 2022 Oct 31 doi: 10.22092/ARI.2022.359504.2435. PMID: 37123118Free PMC Article
Culos KA, Gatwood KS, Byrne M
Pharmacotherapy 2020 Aug;40(8):727-740. Epub 2020 May 19 doi: 10.1002/phar.2407. PMID: 32343426
Zhao Y, Huang H, Wei G
J Hematol Oncol 2013 Jun 18;6:40. doi: 10.1186/1756-8722-6-40. PMID: 23773228Free PMC Article
Pagano L, Caira M
Curr Opin Infect Dis 2012 Dec;25(6):612-8. doi: 10.1097/QCO.0b013e328358b000. PMID: 22964946
Crespo-Solís E
Hematology 2012 Apr;17 Suppl 1:S169-73. doi: 10.1179/102453312X13336169156852. PMID: 22507812

Diagnosis

Alrobaian MA, Henderson AD
J Neuroophthalmol 2021 Dec 1;41(4):e584-e590. doi: 10.1097/WNO.0000000000001071. PMID: 32868572
Dabas R, Khan PD, Modi M, Khan FM, Storek J
Cytotherapy 2019 Nov;21(11):1161-1165. Epub 2019 Sep 19 doi: 10.1016/j.jcyt.2019.08.003. PMID: 31543396
Khan M, Siddiqi R, Naqvi K
Ann Hematol 2018 Jun;97(6):945-953. Epub 2018 Mar 15 doi: 10.1007/s00277-018-3297-6. PMID: 29546454
Almaiman AA
J Coll Physicians Surg Pak 2018 Feb;28(2):133-145. doi: 10.29271/jcpsp.2018.02.133. PMID: 29394974
Bleyer WA
Pediatr Ann 1983 Apr;12(4):277-92. doi: 10.3928/0090-4481-19830401-02. PMID: 6346242

Therapy

Culos KA, Gatwood KS, Byrne M
Pharmacotherapy 2020 Aug;40(8):727-740. Epub 2020 May 19 doi: 10.1002/phar.2407. PMID: 32343426
Khan M, Siddiqi R, Naqvi K
Ann Hematol 2018 Jun;97(6):945-953. Epub 2018 Mar 15 doi: 10.1007/s00277-018-3297-6. PMID: 29546454
Almaiman AA
J Coll Physicians Surg Pak 2018 Feb;28(2):133-145. doi: 10.29271/jcpsp.2018.02.133. PMID: 29394974
Greenblatt SM, Nimer SD
Leukemia 2014 Jul;28(7):1396-406. Epub 2014 Mar 10 doi: 10.1038/leu.2014.94. PMID: 24609046Free PMC Article
Levine RL
Curr Top Microbiol Immunol 2012;355:119-33. doi: 10.1007/82_2011_170. PMID: 21823028

Prognosis

Alrobaian MA, Henderson AD
J Neuroophthalmol 2021 Dec 1;41(4):e584-e590. doi: 10.1097/WNO.0000000000001071. PMID: 32868572
Khan M, Siddiqi R, Naqvi K
Ann Hematol 2018 Jun;97(6):945-953. Epub 2018 Mar 15 doi: 10.1007/s00277-018-3297-6. PMID: 29546454
Zhao Y, Huang H, Wei G
J Hematol Oncol 2013 Jun 18;6:40. doi: 10.1186/1756-8722-6-40. PMID: 23773228Free PMC Article
Muntean AG, Hess JL
Annu Rev Pathol 2012;7:283-301. Epub 2011 Oct 17 doi: 10.1146/annurev-pathol-011811-132434. PMID: 22017583Free PMC Article
Bleyer WA
Pediatr Ann 1983 Apr;12(4):277-92. doi: 10.3928/0090-4481-19830401-02. PMID: 6346242

Clinical prediction guides

Mondet J, Chevalier S, Mossuz P
Molecules 2021 Mar 2;26(5) doi: 10.3390/molecules26051323. PMID: 33801279Free PMC Article
Janitz AE, Campbell JE, Magzamen S, Pate A, Stoner JA, Peck JD
Environ Res 2017 Oct;158:167-173. Epub 2017 Jun 20 doi: 10.1016/j.envres.2017.06.015. PMID: 28645022Free PMC Article
Janitz AE, Campbell JE, Magzamen S, Pate A, Stoner JA, Peck JD
Environ Res 2016 Jul;148:102-111. Epub 2016 Mar 31 doi: 10.1016/j.envres.2016.03.036. PMID: 27038831Free PMC Article
Zhao Y, Huang H, Wei G
J Hematol Oncol 2013 Jun 18;6:40. doi: 10.1186/1756-8722-6-40. PMID: 23773228Free PMC Article
Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH
N Engl J Med 2013 Apr 18;368(16):1509-1518. Epub 2013 Mar 25 doi: 10.1056/NEJMoa1215134. PMID: 23527958Free PMC Article

Recent systematic reviews

Godoy PBG, Simionato NM, de Mello CB, Suchecki D
Neuropsychol Rev 2020 Sep;30(3):386-406. Epub 2020 Jul 27 doi: 10.1007/s11065-020-09446-4. PMID: 32720195
Schnatter AR, Chen M, DeVilbiss EA, Lewis RJ, Gallagher EM
J Occup Environ Med 2018 Jul;60(7):e329-e342. doi: 10.1097/JOM.0000000000001336. PMID: 29985303
Cannella L, Caocci G, Jacobs M, Vignetti M, Mandelli F, Efficace F
Crit Rev Oncol Hematol 2015 Dec;96(3):542-54. Epub 2015 Aug 1 doi: 10.1016/j.critrevonc.2015.07.012. PMID: 26324461

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NCCN, 2024
      NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Lymphoblastic Leukemia, 2024

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...